Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

End Tidal Carbon Monoxide (ETCO) : A Tool to Aid Identification of Neonatal Hemolysis

NCT05475223 is registered in ClinicalTrials.gov with Cedars-Sinai Medical Center as lead sponsor.

NCT NCT05475223
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05475223 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
End Tidal Carbon Monoxide (ETCO) : A Tool to Aid Identification of Neonatal Hemolysis
Lead sponsor
Cedars-Sinai Medical Center
Phase
Not applicable
Overall status
Unknown status
Start date
July 29, 2022
Completion date
December 31, 2022
Enrollment
350 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

end tidal carbon monoxide, end tidal carbon monoxide excretion as a diagnostic tool for hemolysis in the newborn, neonatal jaundice